Hydrocodone controlled-release - Purdue Pharma

Drug Profile

Hydrocodone controlled-release - Purdue Pharma

Alternative Names: HYD - Purdue Pharma; hydrocodone bitartrate extended-release - Purdue Pharma; Hydrocodone bitartrate once-daily - Purdue Pharma; Hysingla

Latest Information Update: 04 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Purdue Pharma
  • Class Antitussives; Morphinans; Opioid analgesics; Opioid peptides; Small molecules
  • Mechanism of Action Opioid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Pain

Most Recent Events

  • 21 Apr 2017 Purdue Pharma withdraws prior to enrolment its phase II trial for Pain (In adolescents) in USA (NCT02542098)
  • 08 Sep 2015 Purdue Pharma plans a phase II trial for Pain (In adolescents) in USA (NCT02542098)
  • 13 May 2015 Adverse events data from a phase III trial in Pain presented at the 34th Annual American Pain Society Scientific Meeting (APS-2015)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top